Courvoisier's law
Courvoisier's law (also known as Courvoisier's sign or Courvoisier's rule) is a medical rule that states that in the presence of a palpable gallbladder in a jaundiced patient, the cause is unlikely to be gallstones. This rule is named after the Swiss surgeon Ludwig Georg Courvoisier who first described it.
History[edit]
Ludwig Georg Courvoisier (1843–1918) was a Swiss surgeon who first described the rule that bears his name. He made significant contributions to the field of surgery, particularly in the area of gallbladder diseases.
Explanation[edit]
Courvoisier's law is based on the principle that if the gallbladder is palpable in a patient with jaundice, it is unlikely that the cause of the jaundice is gallstones. This is because gallstones typically cause the gallbladder to shrink due to chronic inflammation, making it non-palpable. Therefore, a palpable gallbladder in a jaundiced patient suggests a different cause, such as a tumor in the head of the pancreas or the ampulla of Vater.
Clinical significance[edit]
Courvoisier's law is used in the differential diagnosis of jaundice. It helps to distinguish between obstructive jaundice caused by gallstones and that caused by other conditions such as pancreatic or ampullary tumors. However, it is not a definitive diagnostic tool and further investigations such as imaging studies and blood tests are usually required to confirm the diagnosis.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
